Association between hs-CRP and HbA1c in overweight type 2 diabetic female patients

Journal of the Medical Association of Thailand

Volumn 96, Issue SUPPL.3, 2013, Pages 54-58

  Sarinnapakorn, Veerasak ^a   Wanicagool, Warangkana ^a  

^a RANGSIT UNIVERSITY   (Thailand)

Author keywords

Hba1c; Hs CRP

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RETROSPECTIVE STUDY;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OVERWEIGHT;

EID: 84876944470     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone- Gastin I, Angioi M, Lozniewski A, et al. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137: 346-51.
2. Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001; 103: 1191-3.
3. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007- 2011.
4. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 1971-7.
5. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996; 82: 245-55.
6. Goldberg RB. Cardiovascular disease in diabetic patients. Med Clin North Am 2000; 84: 81-93.
7. Haque F, Ekram S, Islam QT, Jahan S, Haque Z. Evaluation of serum high sensitivity C-reactive protein (hs-CRP) in type-2 diabetic patient. J Medicine (Bangladesh) 2010; 11: 20-3.
8. Bhowmick K, Kutty AV, Shetty HV. Glycemic control modifies the association between microalbuminuria and c-reactive protein in Type 2 Diabetes Mellitus. Indian J Clin Biochem 2007; 22: 53-9.
9. Amanullah S, Jarari A, Govindan M, Basha MI, Khatheeja S. Association of hs-CRP with diabetic and non-diabetic individuals. Jordan Journal of Biological Sciences 2010; 3: 7-12.
10. King DE, Mainous AG 3rd, Buchanan TA, Pearson WS. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 2003; 26: 1535-1539.
11. Balalcazar M, Reboussin D, Hafffner S, Hoogeveen R, Tracy R, Kriska A, et al. Abstract 1300: Improvement in glucose control with lifestyle intervention reduces C-reactive protein in obese subjects with type 2 diabetes: the look AHEAD study. Circulation 2009; 120: 473-474.